Ensuring the safety of biologic products is critical across every stage of development, manufacturing and release. Increasing regulatory complexity, advancing therapeutic modalities and the need for timely, reliable data make outsourced biosafety testing a strategic priority for pharmaceutical and biotech organizations.

As a world leader in biopharmaceutical testing, we offer a comprehensive range of biologic safety testing aligned with FDA, USP, ICH, Ph. Eur. and WHO guidelines and performed in compliance with GMP regulations. We support outsourced biologic testing across advanced therapies, biologics and vaccines – delivering timely, reliable results for clinical and commercial batch release, with over 95% on-time delivery across all our biosafety departments.